Human Resources
Takeda, Roche Diagnostics, BMS and Gilead earn LGBTQ+ inclusion recognition
Takeda Pharmaceuticals Australia has secured Bronze status in the Australian Workplace Equality Index (AWEI), the national benchmark for LGBTQ+ workplace […]
MoreHuman Resources
Nation-first right to work from home set to redefine employer obligations
Flexible working arrangements have become a defining battleground for employee satisfaction and retention, particularly as organisations have accelerated the return […]
MoreHuman Resources
French Ambassador officiates opening of Sanofi’s Barangaroo headquarters
Sanofi has officially opened the doors to its new headquarters at International Towers, Barangaroo, marking the milestone with a ceremony […]
MoreHuman Resources
AbbVie, Medtronic and Pfizer crowned Best Workplaces for Women
AbbVie, Medtronic and Pfizer are the only companies from the pharma and medtech sectors named in the 2026 list of […]
MoreHuman Resources
How pharma, medtech and diagnostics sectors stack up in new gender pay gap report
Newly released gender pay gap data exposes the state of workplace equality for over 5.9 million Australians. The Workplace Gender […]
MoreHuman Resources
Navigating the rules of leadership, workforce and workplaces: Experts decode 2026 trends
After a year many leaders describe as ‘relentless’, the pharma, medtech, and diagnostics industry is entering 2026 with the rules […]
MoreHuman Resources
Sanofi and AbbVie invest in modern, collaborative workspaces in Sydney CBD
Sanofi has officially welcomed employees to its new headquarters for Australia and New Zealand at International Towers, Barangaroo, marking the […]
MoreHuman Resources
Boehringer Ingelheim and Takeda set the bar high in workplace excellence
Boehringer Ingelheim and Takeda have been recognised as leading employers, each earning accolades that reflect sustained investment in people, culture, […]
MoreHuman Resources
Johnson & Johnson integrates ANZ operations in future-ready Macquarie Park headquarters
Johnson & Johnson has officially opened its new headquarters at MPark, a purpose-built hub for innovation, life sciences and technology […]
MoreHuman Resources
The $1.5 million penalty: Women pay the price for Australia’s gender pay gap
For women in Australia, that gender pay gap widens with age, peaking in the late 50s at a jaw-dropping $53,000 […]
MoreRecent Posts in Pharma, MedTech & Biotech
David Henderson appointed Takeda Oceania Country Head
August 10, 2026
in Leadership & Management
GBMA puts medicine shortages on the table as strategic agreement talks begin
August 10, 2026
in News - Pharmaceuticals
Australia sets a new course for prostate cancer detection
August 10, 2026
in News - MedTech & Diagnostics
IVF success rates climb as ART sector faces major accreditation overhaul
August 10, 2026
in News - Pharmaceuticals
‘Get comfortable being uncomfortable,’ urges Medtronic VP and Managing Director
August 7, 2026
in News - MedTech & Diagnostics
Department of Health halts PL changes as industry warns of device viability
August 7, 2026
in News - MedTech & Diagnostics
argenx inks new agreement with Australian regenerative medicine biotech
August 7, 2026
in News - Biotechnology
The human faces rewriting Australia’s most common rare disease, cystic fibrosis
August 7, 2026
in News - Pharmaceuticals
Follow Us
Partner with us
Leadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
MoreNews - Pharmaceuticals
GBMA puts medicine shortages on the table as strategic agreement talks begin
As the Generic and Biosimilar Medicines Association (GBMA) begins negotiations with government on the next strategic agreement, it has unveiled […]
MoreNews - MedTech & Diagnostics
Australia sets a new course for prostate cancer detection
Australia has become one of the first countries in the world to adopt a modern, evidence-based framework for the early […]
MoreNews - Pharmaceuticals
IVF success rates climb as ART sector faces major accreditation overhaul
Australians undergoing in vitro fertilisation (IVF) are now more likely to take home a baby than they were five years […]
More